NASDAQ:HUMA (Humacyte Inc.)

About HUMA

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions.
  • Humacyte Inc. (NASDAQ: HUMA) Latest News

    No posts found.